Atlas Trials

Trial of 6% HES130/0.4

Clinical trial NCT01010022 · COMPLETED

Trial details

NCT number
NCT01010022
Sponsor
Fresenius Kabi Japan
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HypovolemiaHemorrhage
Start date
2009-11-01
Primary completion
2010-07-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.